stockrow
Friday 6 November 2026
Export KOD’s income statement to Excel — free account
Kodiak Sciences Inc.
- EPS
- −1.94%
- Free cash flow
- −33.9%
Quarter to June 2026, against a year earlier
98.85
7.83
+8.60%
Follow KOD
Alert me
Kodiak Sciences Inc. (KOD) Current ratio
Kodiak Sciences Inc.'s current ratio at the end of the quarter to 30 June 2026 was 2.5×, down 2.2× from fiscal 2025 (4.7×). Over the past ten years it has ranged from 0.2× (fiscal 2017) to 30.9× (fiscal 2020); the current reading is higher than 30% of that period. That is below the Biotechnology industry median of 4.9× and below the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 4.7× | (29.83%) |
| FY2024 | 6.7× | (3.02%) |
| FY2023 | 6.9× | (25.11%) |
| FY2022 | 9.3× | (18.51%) |
| FY2021 | 11.4× | (63.28%) |
| FY2020 | 30.9× | 6.79% |
| FY2019 | 29.0× | 54.56% |
| FY2018 | 18.7× | 10,658.90% |
| FY2017 | 0.2× | (95.71%) |
| FY2016 | 4.1× | — |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Jun 2026 | 2.5× | (29.59%) |
| Mar 2026 | 3.5× | (25.06%) |
| Dec 2025 | 4.7× | 164.33% |
| Sep 2025 | 1.8× | (48.71%) |
| 29 more quarters | Free account |
Against its own ten years
Low 0.2×
High 30.9×
Ten-year median
8.1×
Current reading's percentile
30
Current ratio against peers
| Company | Current ratio |
|---|---|
| ORKA Oruka Therapeutics, Inc. compare | 38.5× |
| BLTE Belite Bio, Inc. Sponsored ADR compare | 33.6× |
| CGON CG Oncology, Inc. compare | 22.2× |
| IONS Ionis Pharmaceuticals, Inc. compare | 7.9× |
| IMVT Immunovant, Inc. compare | 7.3× |
| PTCT PTC Therapeutics, Inc. compare | 3.3× |
| KOD Kodiak Sciences Inc. | 2.5× |
| MIRM Mirum Pharmaceuticals, Inc. compare | 2.1× |
| LGND Ligand Pharmaceuticals Incorporated compare | 1.2× |
| Biotechnology industry median | 4.9× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)